Autoantibodies in autoimmune hepatitis: Anti-asialoglycoprotein receptor (anti-ASGPR) antibodies

Clinics and Research in Hepatology and Gastroenterology

Volumn 36, Issue 5, 2012, Pages 510-512

  Chantran, Yannick ^a   Ballot, Eric ^a   Johanet, Catherine ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASIALOGLYCOPROTEIN RECEPTOR ANTIBODY; AUTOANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEPATITIS; DISEASE ACTIVITY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PROGNOSIS; TREATMENT RESPONSE;

ASIALOGLYCOPROTEIN RECEPTOR; AUTOANTIBODIES; HEPATITIS, AUTOIMMUNE; HUMANS;

EID: 84868380674     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2012.07.013     Document Type: Article

References (27)

1. Alvarez F., Berg P.A., Bianchi F.B., Bianchi L., Burroughs A.K., Cancado E.L., et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999, 31:929-938.
2. Hennes E.M., Zeniya M., Czaja A.J., Pares A., Dalekos G.N., Krawitt E.L., et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008, 48:169-176.
3. Jensen D.M., McFarlane I.G., Portmann B.S., Eddleston A.L., Williams R. Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis. N Engl J Med 1978, 299:1-7.
4. McFarlane I.G., McFarlane B.M., Major G.N., Tolley P., Williams R. Identification of the hepatic asialo-glycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP). Clin Exp Immunol 1984, 55:347-354.
5. McFarlane B.M., McSorley C.G., McFarlane I.G., Williams R. A radioimunoassay for detection of circulating antibodies reacting with the hepatic asialoglycoprotein receptor protein. J Immunol Methods 1985, 77:219-228.
6. Treichel U., Schreiter T., Meyer zum Büschenfelde K.H., Stockert R.J. High-yield purification and characterisation of human asialoglycoprotein receptor. Protein Expr Purif 1995, 6:251-255.
7. Schwartz A.L., Marshak-Rothstein A., Rup D., Lodish H.F. Identification and quantification of the rat hepatocyte asialoglycoprotein receptor. Proc Natl Acad Sci 1978, 6:3348-3352.
8. Hausdorf G., Roggenbuck D., Feist E., Büttner T., Jungblut P.R., Conrad K., et al. Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA - revival of a disease-activity marker in autoimmune hepatitis. Clin Chim Acta 2009, 408:19-24.
9. Yoshioka M., Mizuno M., Morisue Y., Shimada M., Hirai M., Nasu J., et al. Anti-asialoglycoprotein receptor autoantibodies detected by a capture-immunoassay are associated with autoimmune liver diseases. Acta Med Okayama 2002, 56:99-105.
10. Schreiter T., Liu C., Gerken G., Treichel U. Detection of circulating autoantibodies directed against the asialoglycoprotein receptor using recombinant receptor subunit H1. J Immunol Methods 2005, 301:1-10.
11. Treichel U., Poralla T., Hess G., Manns M., Meyer zum Büschenfelde K.H. Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis. Hepatology 1990, 11:606-612.
12. Poralla T., Treichel U., Löhr H., Fleischer B. The asialoglycoprotein receptor as target structure in autoimmune liver diseases. Semin Liver Dis 1991, 11:215-222.
13. Johnson P.J., McFarlane I.G., McFarlane B.M., Williams R. Auto-immune features in patients with idiopathic chronic active hepatitis who are seronegative for conventional auto-antibodies. J Gastroenterol Hepatol 1990, 5:244-251.
14. Treichel U., McFarlane B.M., Seki T., Krawitt E.L., Alessi N., Stickel F., et al. Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis. Gastroenterol 1994, 107:799-804.
15. Gregorio G.V., McFarlane B., Bracken P., Vergani D., Mieli-Vergani G. Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease. Autoimmunity 2002, 35:515-519.
16. Czaja A.J., Pfeifer K.D., Decker R.H., Vallari A.S. Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis. Dig Dis Sci 1996, 41:1733-1740.
17. Rigopoulou E.L., Roggenbuck D., Smyk D.S., Liaskos C., Mytilinaiou M.G., Feist E., et al. Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found. Autoimmun Rev 2012, 10.1016/j.autrev.2012.04.005.
18. Meyer zum Büschenfelde K.H., Treichel U., Löhr H., Fleischer B., Poralla T. Human asialoglycoprotein receptor as an autoantigen in chronic hepatitis. Immunol Res 1991, 10:497-502.
19. Treichel U., Gerken G., Rossol S., Rotthauwe H.W., Meyer zum Büschenfelde K.H., Poralla T. Autoantibodies against the human asialoglycoprotein receptor: effects of therapy in autoimmune and virus-induced chronic active hepatitis. J Hepatol 1993, 19:55-63.
20. McFarlane I.G., Hegarty J.E., McSorley C.G., McFarlane B.M., Williams R. Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis. Lancet 1984, 8409:954-956.
21. Meyer zum Büschenfelde K.H., Hopf U. Studies on the pathogenesis of experimental chronic active hepatitis in rabbits. I. Induction of the disease and protective effect of allogeneic liver specific proteins. Br J Exp Pathol 1974, 555:498-508.
22. Vergani D., Mieli-Vergani G. Aetiopathogenesis of autoimmune hepatitis. World J Gastroenterol 2008, 14:3306-3312.
23. Vergani D., Mieli-Vergani G., Mondelli M., Portmann B., Eddleston A.L. Immunoglobulin on the surface of isolated hepatocytes is associated with antibody-dependent cell-mediated cytotoxicity and liver damage. Liver 1987, 7:307-315.
24. Hajoui O., Martin S., Alvarez F. Study of antigenic sites on the asialoglycoprotein receptor recognized by autoantibodies. Clin Exp Immunol 1998, 113:339-345.
25. McFarlane B.M., Sipos J., Gove C.D., McFarlane I.G., Williams R. Antibodies against the hepatic asialoglycoprotein receptor perfused in situ preferentially attach to periportal liver cells in the rat. Hepatology 1990, 11:408-415.
26. O'Brien C.J., Vento S., Donaldson P.T., McSorley C.G., McFarlane I.G., Williams R., et al. Cell-mediated immunity and suppressor-T-cell defects to liver-derived antigens in families of patients with autoimmune chronic active hepatitis. Lancet 1986, 8477:350-353.
27. Löhr H., Treichel U., Poralla T., Manns M., Meyer zum Büschenfelde K.H. Liver infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro. Clin Exp Immunol 1992, 88:45-49.